Max Robotics — Global Service Robot Directory + US Certification

About

Fangfang Xie is a prominent pulmonologist and bronchoscopy specialist whose research focuses on advanced minimally invasive techniques for diagnosing peripheral pulmonary lesions. Working at the forefront of interventional pulmonology, Xie has made significant contributions to the clinical evaluation and adoption of shape-sensing robotic-assisted bronchoscopy (ssRAB) technology, particularly within the Chinese medical context. Their landmark 2024 study assessing the feasibility and safety of the ION robotic bronchoscopy platform in Chinese patients — now accumulating 16 citations — provided critical evidence supporting the use of this cutting-edge technology beyond its original U.S.-based clinical trials. Building on this foundation, Xie played a leading role in developing the 2025 Chinese expert consensus on ssRAB for peripheral pulmonary lesion management, helping to standardize clinical practice and accelerate responsible adoption of robotic bronchoscopy across China. This consensus work reflects Xie's broader influence as a thought leader bridging international innovation with regional clinical needs. Their research is particularly timely given the rising incidence of pulmonary nodules detected through screening programs, making their contributions to safer, more precise biopsy techniques increasingly valuable to clinicians and patients alike.